Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

CAPLIPOINT - Swing Trade Analysis with AI Signals

Last Updated Time : 20 Dec 25, 07:00 am

Back to Swing Trade List

Swing Trade Rating: 3.6

Stock Code CAPLIPOINT Market Cap 14,676 Cr. Current Price 1,931 ₹ High / Low 2,641 ₹
Stock P/E 42.0 Book Value 243 ₹ Dividend Yield 0.31 % ROCE 28.6 %
ROE 22.0 % Face Value 2.00 ₹ DMA 50 1,970 ₹ DMA 200 2,010 ₹
Chg in FII Hold 0.35 % Chg in DII Hold -0.12 % PAT Qtr 103 Cr. PAT Prev Qtr 85.9 Cr.
RSI 43.7 MACD -10.2 Volume 30,932 Avg Vol 1Wk 31,016
Low price 1,551 ₹ High price 2,641 ₹ PEG Ratio 1.91 Debt to equity 0.00
52w Index 34.8 % Qtr Profit Var -2.98 % EPS 46.0 ₹ Industry PE 30.6

📊 Caplin Point shows moderate potential for swing trading. The stock is trading below both its 50 DMA (1,970 ₹) and 200 DMA (2,010 ₹), with RSI at 43.7 indicating mildly oversold conditions. MACD is negative (-10.2), suggesting short-term weakness. Strong ROCE (28.6%) and ROE (22.0%) highlight solid fundamentals, though high P/E of 42 compared to industry PE of 30.6 and declining quarterly profits limit upside. Optimal entry would be near 1,900–1,920 ₹. If already holding, consider exiting near 2,000–2,050 ₹ unless momentum strengthens.

✅ Positive

⚠️ Limitation

🚨 Company Negative News

No major fresh negative news reported, but weak quarterly profit growth and reduced DII interest remain concerns.

🌟 Company Positive News

Strong ROCE/ROE, debt-free balance sheet, and rising FII support highlight investor confidence in long-term fundamentals.

🏭 Industry

The pharmaceutical industry trades at an average PE of 30.6. Caplin Point’s valuation is higher, reflecting growth optimism but also overvaluation risk.

📌 Conclusion

Caplin Point is a fair swing trade candidate with strong fundamentals but weak technicals. Best entry near 1,900–1,920 ₹ (close to support levels). If already holding, exit near 2,000–2,050 ₹ unless momentum breaks resistance. Risk-reward is moderate, with caution advised due to high valuation and bearish indicators.

Would you like me to extend this into a peer comparison with Sun Pharma and Divi’s Labs to highlight relative swing trade opportunities in the pharma sector?

Back to Swing Trade List

NIFTY 50 - Today Top Swing Trade Stock Picks

NEXT 50 - Today Top Swing Trade Stock Picks

MIDCAP - Today Top Swing Trade Stock Picks

SMALLCAP - Today Top Swing Trade Stock Picks